FABP4 and breast cancer: Cytoplasmic fatty acid binding protein 4 (FABP4) induces insulin resistance by upregulating glucose production, and high circulating levels of FABP4 independently predict cardiometabolic risk and the risk of type 2 diabetes and breast cancer [43,44,45,46].